ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.598,29
-0,46%
S&P 500
5.306,04
0,02%
Dow Jones
38.852,86
-0,55%
Euro vs US Dollar
1,08382
-0,14%
Bitcoin
67.830,27
-0,67%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. IDEAYA Biosciences Inc (IDYA)

  7. IDEAYA Biosciences Inc (IDYA) News

IDYA IDEAYA Biosciences Inc

37,53
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:09:37
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
IDEAYA Biosciences Inc IDYA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 37,53 10:09:37
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
37,53
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
28.5.202412:00PRNUSIDEAYA Biosciences Appoints Daniel A. Simon as Chief..
24.5.202403:21PRNUS/C O R R E C T I O N -- IDEAYA Biosciences, Inc./
23.5.202423:05PRNUSIDEAYA Biosciences Announces Abstract Summary Results of..
07.5.202412:04EDGAR2Form 8-K - Current report
07.5.202412:00PRNUSIDEAYA Biosciences, Inc. Reports First Quarter 2024..
01.5.202412:00PRNUSIDEAYA Biosciences to Participate in Upcoming May 2024..
26.4.202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
24.4.202416:05PRNUSIDEAYA Biosciences Announces ASCO 2024 Oral Presentation for..
22.4.202412:00PRNUSIDEAYA Biosciences Announces Selection of Move-Forward Phase..
05.4.202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
01.4.202412:00PRNUSIDEAYA Biosciences to Participate in Upcoming April 2024..
12.3.202411:00PRNUSIDEAYA Announces Clinical Collaboration to Evaluate IDE161..
04.3.202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202412:00PRNUSIDEAYA Biosciences to Participate in Upcoming March 2024..
20.2.202422:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
20.2.202412:07EDGAR2Form 8-K - Current report
20.2.202412:00PRNUSIDEAYA Biosciences, Inc. Reports Fourth Quarter and..
14.2.202412:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202401:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202423:56EDGAR2Form 144 - Report of proposed sale of securities
01.2.202412:00PRNUSIDEAYA Biosciences to Participate in Upcoming February 2024..
26.1.202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
25.1.202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202412:03EDGAR2Form 8-K - Current report
19.1.202423:18EDGAR2Form 8-K - Current report
19.1.202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17.1.202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202412:07EDGAR2Form 8-K - Current report
12.1.202422:24EDGAR2Form 144 - Report of proposed sale of securities
12.1.202412:04EDGAR2Form 8-K - Current report
07.1.202415:00PRNUSIDEAYA Biosciences Announces Participation at the 42nd..
29.12.202312:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
27.12.202322:24EDGAR2Form 144 - Report of proposed sale of securities
19.12.202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.12.202301:09EDGAR2Form 144 - Report of proposed sale of securities
15.12.202301:29EDGAR2Form 144 - Report of proposed sale of securities
11.12.202323:45EDGAR2Form 144 - Report of proposed sale of securities
08.12.202312:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
05.12.202312:00PRNUSIDEAYA Biosciences to Participate in Upcoming December 2023..
04.12.202323:02EDGAR2Form 144 - Report of proposed sale of securities
04.12.202312:04EDGAR2Form 8-K - Current report
04.12.202312:00PRNUSIDEAYA Announces Clinical Study Collaboration with Gilead..
03.12.202315:00PRNUSIDEAYA Announces Agenda for Investor R&D Day Webcast on..
28.11.202323:50EDGAR2Form 144 - Report of proposed sale of securities
27.11.202323:21EDGAR2Form 144 - Report of proposed sale of securities
17.11.202312:02EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
IDYA
IDEAYA Biosciences
NASDAQ
SBSE
Sbs Technologies
NASDAQ
ONFO
Onfolio
BIT
P11CV2
Bnp Paribas Issuance
BIT
P1SL49
BNP Paribas Issuance
BOV
N1IC34
NICE
BIT
P1PP63
BNP Paribas Issuance
BIT
P1M6J5
BNP Paribas Issuance
BIT
P1SOU2
BNP Paribas Issuance
UNSW3
CVXCRVETH
Convex CRV
BIT
UC1H00
Unicredit Bank
NYSE
CYF.L
Lehman Abs Safeco
LSE
GB58
Euro.bk.31
ASX
EM2R
Eagle Mountain Mining
BIT
I09192
Intesa Sanpaolo
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten